ArticleCureus2025
Clinical and Inflammatory Correlates of Negative Symptom Dimensions in Schizophrenia: Cross-Sectional Evidence for Neutrophil-to-Lymphocyte Ratio Associations With Motivational Deficits in Hospitalized Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study examined negative symptom dimensions and their biological correlates in patients with schizophrenia under routine hospital conditions.
objectiveTo assess whether demographic, clinical, and inflammatory markers, that is, C-reactive protein (CRP), complement component 4 (C4), and the neutrophil-to-lymphocyte ratio (NLR), contribute to variation across negative symptom domains measured using two complementary instruments. METHODOLOGY: A cross-sectional study was conducted at the Clinics I-II of Psychiatry, Cluj-Napoca, Romania (May-September 2023). Forty-five inpatients with schizophrenia were evaluated using the Brief Negative Symptom Scale (BNSS) and the Positive and Negative Syndrome Scale (PANSS). Fasting CRP and C4 were measured, and NLR was calculated from differential blood counts. Analyses included descriptive statistics, Shapiro-Wilk testing, parametric/nonparametric comparisons, and Pearson/Spearman correlations. Multiple linear regressions included biomarkers as predictors and were adjusted for sex, age, body mass index (BMI), smoking, chlorpromazine-equivalent dose, and clozapine treatment; models were compared using Akaike Information Criterion (AIC) (ΔAIC ≤ 2). Sensitivity analyses excluded clozapine-treated patients and additionally adjusted for PANSS Positive and General Psychopathology totals.
resultsBMI correlated negatively with negative symptoms (PANSS negative: ρ = -.43) and positively with CRP (ρ = .67). Stratified analyses revealed a CRP-Avolition association in non-overweight patients (ρ = .49) and stronger neutrophil-to-lymphocyte ratio (NLR)-motivational domain correlations in clozapine-treated patients (Asociality/Motivation and Pleasure (MAP): ρ = .59-.66). In covariate-adjusted, AIC-selected models, NLR remained significant for Asociality, PANSS Emotional Withdrawal, and MAP (adjusted R² = .19-.24; partial R² = .10-.16). CRP was retained only for Avolition with limited explained variance (adjusted R² = .03; partial R² = .09). C4 did not enter any final model.
conclusionIn this inpatient cohort, NLR was the most consistent correlate of motivational negative symptoms, while CRP showed a weak association with Avolition, and C4 showed no clear relationship. Findings are hypothesis-generating and require replication in larger, longitudinal samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.